Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
This study investigates the potential anti-epileptic properties of glycitin in the context of pentylenetetrazol (PTZ) induced seizures in male Wistar rats
Find out if that clinic has a registered dietitian on staff or can refer patients to one
As we age, we experience a decline in the production of keratin causing our hair and nails to become brittle, discolored or dull, as well as leading to splitting or cracking
Nature 454 , 455462 (2008)
GLP-1 medications like Ozempic, Mounjaro, and Wegovy are commonly prescribed to help manage type 2 diabetes and support weight loss
GLP-1 Receptor Agonist Market Report 2026 Global Outlook By Drug Class (Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs), By Route Of Administration (Parenteral, Oral), By End Users (Hospitals, Surgical Clinics, Other Users) Market Size, Trends, Strategies, and Forecast to 2035 GLP-1 Receptor Agonist Market Overview GLP-1 Receptor Agonist market size has reached to $14.09 billion in 2025 Expected to grow to $18.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.4% Growth Driver: Surging Diabetes Cases Fuel Growth In Glp-1 Receptor Agonist Market Market Trend: Sustained-Release Glp-1 Receptor Agonists Are Gaining Popularity North America was the largest region in 2025 and Asia-Pacific is the fastest growing region
US$ 20.12
US$ 24.20
US$ 23.78
US$ 27.66
US$ 22.16
